Emory University Winship Cancer Institute — Atlanta, Georgia

Public research footprint of Emory University Winship Cancer Institute, compiled from the ClinicalTrials.gov public registry.

293

Registered studies

Active

Recruiting now

160

Completed

Stopped or withdrawn

Most-studied conditions

Chronic Lymphocytic Leukemia · Acute Myeloid Leukemia · Multiple Myeloma · Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

Recently updated registry entries

NCT04554914 — A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV)… (Active Not Recruiting)
NCT06095089 — A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer (Recruiting)
NCT03767244 — A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Emory University Winship Cancer Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.